Similar articles

• [Anti-arrhythmic efficacy of aprindine during the acute phase of myocardial infarct].

  Hagemeijer F, Janse C, Hugenholtz PG. Hagemeijer F, et al. Acta Cardiol. 1974;Suppl 18:409-21. Acta Cardiol. 1974. PMID: 4138502 Clinical Trial. French. No abstract available.
• The prophylactic use of anti-arrhythmic drugs in acute myocardial infarction.

  Chung EK. Chung EK. Singapore Med J. 1973 Sep;14(3):205-10. Singapore Med J. 1973. PMID: 4591400 Review. No abstract available.
• [Effect of prophylactic antiarrhythmic treatment on the incidence of ventricular arrhythmias in the postinfarction period (author's transl)].

  Wolf R, Sinn R, Guillen R. Wolf R, et al. Z Kardiol. 1982 Jan;71(1):26-30. Z Kardiol. 1982. PMID: 6175118 German. No abstract available.
• [Comparison of aprindine (AC 1802) and lidocaine by intravenous route during the acute phase of myocardial infarct].

  Depaepe A, Bohyn P, De Maertelaere M, Dernier J, Cloetens W, De Mey D. Depaepe A, et al. Acta Cardiol. 1974;Suppl 18:423-32. Acta Cardiol. 1974. PMID: 4138738 French. No abstract available.
• Current understanding of lidocaine as an antiarrhythmic agent: a review.

  Anderson JL. Anderson JL. Clin Ther. 1984;6(2):125-41. Clin Ther. 1984. PMID: 6200230 Review.